Rohto Pharmaceutical: [Delayed] This is a notice of convocation for the 88th regular shareholders' meeting.
Rohto Pharmaceutical: Independent Company Executives Declaration
Rohto Pharmaceutical: Acquisition of shares in the Austrian pharmaceutical company Mono Chemical Farm Products.
Rohto Pharmaceutical: Regarding the acquisition of shares of Mono chem-pharm Produkte GmbH, an Austrian pharmaceutical company.
Rohto Pharmaceutical: 88th regular shareholder meeting and other electronic provision measures (omitted matters not provided in writing).
Rohto Pharmaceutical: Notice of the 88th regular shareholder meeting.
Rohto Pharmaceutical: Announcements of individual stocks regarding the public tender offer for shares of Eu Yan Sang International Ltd., a Singaporean traditional chinese medicine manufacturer and distributor, by Soar R2M Pte. Ltd.
Rohto Pharmaceutical: Extraordinary Report
Rohto Pharmaceutical: [Corrections and apologies] Notice regarding changes in officers
Rohto Pharmaceutical: Notice regarding changes in officers
Rohto Pharmaceutical: Consolidated financial results for the fiscal year ended March 31, 2024
Rohto Pharmaceutical: Rohto Pharmaceutical Co., Ltd. 88th term (2023) reference materials
Rohto Pharmaceutical: Financial results briefing for the fiscal year ending March 2024
Rohto Pharmaceutical: Summary of financial results for the fiscal year ending March 31, 2024 [Japanese GAAP] (consolidated)
Rohto Pharmaceutical: [Update] [Postponed] Stock Acquisition and Tender Offer for Yu Yangsan International Co., Ltd.
Rohto Pharmaceutical: Acquisition of shares in and tender offer for Eu Yan Sang International Ltd, a Singapore health and wellness manufacturing and sales company
Rohto Pharmaceutical: Acquisition of shares in the Singaporean Chinese medicine manufacturing and sales company Eu Yan Sang International Ltd. (making it a subsidiary company) and commencement of a public tender offer against the company
Rohto Pharmaceutical: Capital alliance and license agreement concluded with therapeutic application development startup S-Alpha
Rohto Pharmaceutical: Notice regarding investment in FiNC Technologies Co., Ltd.
Rohto Pharmaceutical: Notice regarding a capital alliance with Innojin, a university startup working on medical DX
No Data